Bringing the Oncology Community Together
Genes That Drive Clear-Cell RCC Discovered, Providing Research Clues
A genomic analysis of renal cell carcinoma (RCC) has uncovered new clues about the development, growth, and spread of the cancer.
Read More >>
In 2 Cancers, Robotic Versus Open Surgery is Explored
Regional Cancer Care Associates Delivers Value-Based Care
Cell-Cycle Gene Test Shows Early Promise in Clear Cell RCC
AGS-003 to Be Tested With Sunitinib as RCC Treatment
Downregulated Oncogene Raises OS in Obese Patients With RCC
Unprecedented Changes in Oncology: Toward a New Dawn
View More >>
- A Network of Your Peers
View more >>
Alternative Dosing Schedules for Targeted Agents in RCC
Role of Cytoreductive Nephrectomy in mRCC
Risk Stratification in Renal Cell Carcinoma
Most Popular Right Now
Tweets by @OncLive
Minimizing Toxicity While Maintaining Efficacy in RCC
Moderated by Robert A. Figlin, MD, this panel discussion includes expert perspectives from Daniel J. George, MD, Sumanta Kumar Pal, MD, Brian I. Rini, MD, and Nizar M. Tannir, MD.
Avastin (bevacizumab) Plus IFN in mRCC
Ronald Bukowski, MD, and Thomas Hutson, DO, PharmD, disucss bevacizumab in metastatic renal cell carcinoma.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.